5-Hydroxy-3-methyl-1,2,4-oxadiazole - CAS 52386-40-0
Catalog: |
BB027808 |
Product Name: |
5-Hydroxy-3-methyl-1,2,4-oxadiazole |
CAS: |
52386-40-0 |
Synonyms: |
3-methyl-4H-1,2,4-oxadiazol-5-one; 3-methyl-4H-1,2,4-oxadiazol-5-one |
IUPAC Name: | 3-methyl-4H-1,2,4-oxadiazol-5-one |
Description: | 5-Hydroxy-3-methyl-1,2,4-oxadiazole (CAS# 52386-40-0) is a useful research chemical. |
Molecular Weight: | 100.08 |
Molecular Formula: | C3H4N2O2 |
Canonical SMILES: | CC1=NOC(=O)N1 |
InChI: | InChI=1S/C3H4N2O2/c1-2-4-3(6)7-5-2/h1H3,(H,4,5,6) |
InChI Key: | RKRLQDJTVWZXMM-UHFFFAOYSA-N |
LogP: | 0.08360 |
GHS Hazard Statement: | H302 (33.33%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P305+P351+P338, P312, P321, P322, P330, P332+P313, P337+P313, P362, P363, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021195599-A1 | Mtorc1 modulators and uses thereof | 20200327 |
WO-2021160127-A1 | Heterocyclic glp-1 agonists | 20200213 |
US-2021171475-A1 | Compounds | 20180831 |
WO-2020030781-A1 | Tricyclic inhibitors of hepatitis b virus | 20180810 |
CN-113272309-A | Tricyclic inhibitors of hepatitis B virus | 20180810 |
Complexity: | 129 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 100.027277375 |
Formal Charge: | 0 |
Heavy Atom Count: | 7 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 100.027277375 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 50.7 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.2 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Alcohols and Derivatives
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS